Ads
related to: ALDX
Search results
Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why
Zacks via Yahoo Finance· 2 weeks agoAldeyra (ALDX) rises 43% in one week, driven by plans to initiate a pivotal study to support the...
Can Aldeyra Therapeutics, Inc. (ALDX) Climb 107.66% to Reach the Level Wall Street Analysts Expect?
Zacks via Yahoo Finance· 9 months agoThe mean of analysts' price targets for Aldeyra Therapeutics, Inc. (ALDX) points to a 107.7% upside...
Aldeyra Therapeutics, Inc. (ALDX) Now Trades Above Golden Cross: Time to Buy?
Zacks via Yahoo Finance· 2 years agoFrom a technical perspective, Aldeyra Therapeutics, Inc. (ALDX) is looking like an interesting pick,...
Aldeyra's (ALDX) Dry Eye Disease Chamber Study Meets Goals
Zacks via Yahoo Finance· 2 years agoAldeyra's (ALDX) vehicle-controlled crossover study evaluating 0.25% reproxalap ophthalmic solution...
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) has caught the attention of institutional investors who...
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights Institutions' substantial holdings in Aldeyra Therapeutics implies that they have...
Institutions own 37% of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares but retail investors control...
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights Significant control over Aldeyra Therapeutics by retail investors implies that the...
Owning 48% shares,institutional owners seem interested in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX),
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), then you'll have...
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Is About To Turn The Corner
Simply Wall St. via Yahoo Finance· 2 weeks agoAldeyra Therapeutics, Inc. (NASDAQ:ALDX) is possibly approaching a major achievement in its...
Insiders made the right call by buying US$1.2m Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) stock this...
Simply Wall St. via Yahoo Finance· 1 year agoInsiders who bought Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) in the last 12 months may probably not...
Why Aldeyra Therapeutics' Shares Are Soaring Today?
Benzinga via Yahoo Finance· 2 years agoAldeyra Therapeutics Inc's (NASDAQ: ALDX) Phase 3 TRANQUILITY-2 trial of reproxalap for dry eye disease has achieved the primary endpoint. Reproxalap was...